Everything you need to win Robert DiFazio — in one platform.
Who to reach, what to say, and why now on Robert DiFazio — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Robert DiFazio — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Parallel Bio Appoints Ari Gesher As Head of Technology
PRIVATEJun 26, 2024•almost 2 years ago
Position
Chief Executive Officer
Company
Parallel Bio
Robert DiFazio
Cambridge
Description
Ari Gesher has joined Parallel Bio as the first head of technology. He will oversee technical infrastructure and the development of advanced AI and robotics infrastructure to rapidly scale its immune organoid platform for drug discovery. He will work with the co-founders on advancing its immune system platform.
Company Information
Company
Parallel Bio
Location
Cambridge, Maryland, United States
About
Parallel Bio unlocks the human body’s own power to cure disease. It developed the first platform that replicates the human immune system in a dish for drug discovery and development. It models human disease more realistically and accurately than animal testing—leading to the fastest path to treatments and cures that work for more people. Through its combination of immune organoids, machine learning and robotics, the platform represents the complexity of disease and the diversity of patients at population scale. Based in Cambridge, Mass., the company was founded in 2021 by two scientists responsible for creating the world’s first scalable human immune organoid. Learn more at https://www.parallel.bio.
Predictive Intelligence
Strategic
ML-powered predictions for Parallel Bio's next move
Cambridge